Soluble forms of CLEC2 are released upon platelet activation and the elevated sCLEC-2 levels were reported in patients with acute coronary syndrome [18] or acute cerebral infarction [19] without thrombocytopenia, suggesting that sCLEC2 levels may reflect platelet activation in atherosclerotic thrombosis. This evidence concerns the gene CLEC1B and acute coronary syndrome.